Incarceration is a major risk factor for blood-borne infection among intravenous drug users

Hepatitis Monthly

Volumn 11, Issue 1, 2011, Pages 19-22

  Mir Nasseri, Mohammad Mehdi ^a   Mohammadkhani, Ashraf ^a   Tavakkoli, Hamid ^b   Ansari, Esmaeil ^a   Poustchi, Hossein ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ALZAHRA UNIVERSITY   (Iran)

Author keywords

Drug abuse; Hepatitis B; Hepatitis C; HIV; Intravenous; Prison

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; IRAN; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRISON; SENSITIVITY AND SPECIFICITY;

EID: 79956216405     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Levine OS, Vlahov D, Koehler J, Cohn S, Spronk AM, Nelson KE. Seroepidemiology of hepatitis B virus in a population of injecting drug users. Association with drug injection patterns. Am J Epidemiol. 1995;142(3):331-41.
2. Tor J, Llibre JM, Carbonell M, Muga R, Ribera A, Soriano V, et al. Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV. BMJ. 1990;301(6761):1130-3.
3. Muller R, Stark K, Guggenmoos-Holzmann I, Wirth D, Bienzle U. Imprisonment: a risk factor for HIV infection counteracting education and prevention programmes for intravenous drug users. AIDS. 1995;9(2):183-90.
4. Hull HF, Lyons LH, Mann JM, Hadler SC, Steece R, Skeels MR. Incidence of hepatitis B in the penitentiary of New Mexico. Am J Public Health. 1985;75(10):1213-4.
5. Tibbs CJ. Methods of transmission of hepatitis C. J Viral Hepat. 1995;2(3):113-9.
6. Pallas J, Farinas-Alvarez C, Prieto D, Llorca J, Delgado-Rodriguez M. Risk factors for monoinfections and coinfections with HIV, hepatitis B and hepatitis C viruses in northern Spanish prisoners. Epidemiol Infect. 1999;123(1):95-102.
7. Alizadeh AH, Alavian SM, Jafari K, Yazdi N. Prevalence of hepatitis C virus infec tion and its related risk factors in drug abuser prisoners in Hamedan, Iran. World J Gastroenterol. 2005;11(26):4085-9.
8. Davies AG, Dominy NJ, Peters A, Bath GE, Burns SM, Richardson AM. HIV in injecting drug users in Edinburgh: prevalence and correlates. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8(4):399-405.
9. Vlahov D, Nelson KE, Quinn TC, Kendig N. Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur J Epidemiol. 1993;9(5):566-9.
10. Gaughwin MD, Douglas RM, Liew C, Davies L, Mylvaganam A, Treffke H, et al. HIV prevalence and risk behaviours for HIV transmission in South Australian prisons. AIDS. 1991;5(7):845-51.
11. Mirnaseri SMM, Postchi H, Naseri moghadam S, Nouraei SM, Tahaghoghi S, Af shar P, et al. HCV in intravenous drug users. Govaresh J. 2005;10(2):80-6.
12. Patti AM, Santi AL, Pompa MG, Giustini C, Vescia N, Mastroeni I, et al. Viral hepatitis and drugs: a continuing problem. Int J Epidemiol. 1993;22(1):135-9.
13. Vahdani P, Hosseini-Moghaddam SM, Family A, Moheb-Dezfouli R. Prevalence of HBV, HCV, HIV and syphilis among homeless subjects older than fifteen years in Tehran. Arch Iran Med. 2009;12(5):483-7.
14. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol. 2002;17(10):1092-7.
15. Allwright S, Bradley F, Long J, Barry J, Thornton L, Parry JV. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ. 2000;321(7253):78-82.
16. Rowhani-Rahbar A, Tabatabaee-Yazdi A, Panahi M. Prevalence of common blood-borne infections among imprisoned injection drug users in Mashhad, North-East of Iran. Arch Iran Med. 2004;7(3):190-4.
17. Zamani S, Kihara M, Gouya MM, Vazirian M, Ono-Kihara M, Razzaghi EM, et al. Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS. 2005;19(7):709-16.
18. Vanichseni S, Kitayaporn D, Mastro TD, Mock PA, Raktham S, Des Jarlais DC, et al. Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand. AIDS. 2001;15(3):397-405.
19. Zamani S, Ichikawa S, Nassirimanesh B, Vazirian M, Ichikawa K, Gouya MM, et al. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. Int J Drug Policy. 2007;18(5):359-63.
20. Zamani S, Kihara M, Gouya MM, Vazirian M, Nassirimanesh B, Ono-Kihara M, et al. High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. J Acquir Immune Defic Syndr. 2006;42(3):342-6.
21. Hadler SC, Judson FN, O'Malley PM, Altman NL, Penley K, Buchbinder S, et al. Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis. 1991;163(3):454-9.
22. Puoti M, Zanini B, Quinzan GP, Ravasio L, Paraninfo G, Santantonio T, et al. A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patients. J Hepatol. 2004;41(2):312-8.
23. Puoti M, Bruno R, Soriano V, Donato F, Gaeta GB, Quinzan GP, et al. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS. 2004;18(17):2285-93.
24. Singal AK, Anand BS. Management of hepatitis C virus infection in HIV/HCV co-infected patients: clinical review. World J Gastroenterol. 2009;15(30):3713-24.
25. Weinbaum CM, Sabin KM, Santibanez SS. Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention. AIDS. 2005;19(Suppl 3):S41-6.
26. Danta M, Semmo N, Fabris P, Brown D, Pybus OG, Sabin CA, et al. Impact of HIV on host-virus interactions during early hepatitis C virus infection. J Infect Dis. 2008;197(11):1558-66.